Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Biosynth in the transaction. Biosynth, a portfolio company of KKR, announced its acquisition of celares GmbH. The terms and conditions of the...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP advised New York-based investment company KKR & Co. Inc. (KKR) on its acquisition of Clinisupplies from Healthium. KKR was also advised...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher and Selmer advised KKR, while Telenor was guided by Wikborg Rein. Telenor ASA, announced it has sold a 30% stake in its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised KnowBe4 and Potter Anderson & Corroon advised the Special Committee. Latham & Watkins represented Elephant Partners. Gibson, Dunn & Crutcher...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Biosynth Carbosynth, a portfolio company of the KKR Health Care Growth fund, in its acquisition of Pepscan Therapeutics and Pepscan...
You must be a Standard 1 Year member to access this content.
Arthur Cox partnered with Gibson, Dunn & Crutcher LLP in advising Biosynth Carbosynth. Biosynth Carbosynth, a supplier of critical materials to the life science industry, on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Paddle on the deal. Willkie Farr & Gallagher advised FTV Capital, 83North, Notion Capital and Kindred Capital. Gibson, Dunn &...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP acted for KKR Next Generation Technology on its growth investment in +Simple, assisted by Scotto Partners. McDermott represented Tikehau. Hogan Lovells...
You must be a Standard 1 Year member to access this content.
AKD assisted Ncardia on the deal while Sidley Austin represented Kiniciti. Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy, secured more...
You must be a Standard 1 Year member to access this content.
Sidley, Homburger and Wolf Theiss advised KKR on the deal. Bär & Karrer acts as legal advisor to Armira and Dr. Urs Spitz in this transaction....
You must be a Standard 1 Year member to access this content.
Sidley Austin advised KKR on the deal while Orrick represented Salesforce Ventures. KKR and Salesforce Ventures have invested USD62 million in a Series B round for...
You must be a Standard 1 Year member to access this content.
